Taking into account clinical features and genetic test results shows that wild-type RET patients and carriers of MOD risk level variants only differ by family history (p < 0.001), but not by clinical characteristics such as mean age at diagnosis of MTC and cancer stage. This evidence concerns the gene RET and cancer.